Invest in Amatista Biotech

Amatista Biotech is developing a next-generation CAR-T platform designed to deliver safer and more effective cancer therapies.

Our technology has demonstrated positive in vitro and in vivo results, offering a clear pathway to scalable, next-generation treatments.

CAR-T therapy is one of the fastest-growing segments in healthcare. Driven by advances in personalised medicine, it is reshaping cancer treatment by providing highly targeted, patient-specific solutions where traditional therapies fall short. With continued innovation and expanding indications, CAR-T is ushering in a new era of precision oncology.

We are opening our first investment round and seeking VCs, family offices, Business Angels and strategic partners to help scale the future of safer, more accessible CAR-T therapies.